Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Muratova

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular and Biochemical Parasitology|December 1, 1995
Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoesK C Williamson, D B Keister, O Muratova, et al.
Infection and Immunity|September 19, 2000
A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodiesA W Stowers, D B Keister, O Muratova, et al.
The Journal of Experimental Medicine|June 13, 1998
Adherence of erythrocytes during exflagellation of Plasmodium falciparum microgametes is dependent on erythrocyte surface sialic acid and glycophorinsT J Templeton, D B Keister, O Muratova, et al.
Molecular and Biochemical Parasitology|January 1, 1995
A genetic locus on Plasmodium falciparum chromosome 12 linked to a defect in mosquito-infectivity and male gametogenesisA B Vaidya, O Muratova, F Guinet, et al.
Parasite Immunology|September 6, 2000
Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunityP J Bustamante, D C Woodruff, J Oh, et al.
Experimental Parasitology|April 3, 2001
Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidateM M Gozar, O Muratova, D B Keister, et al.
Transfusion Medicine (Oxford, England)|June 20, 2002
In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expressionD R Chambers, J Procter, O Muratova, et al.
The Journal of Cell Biology|October 1, 1996
A developmental defect in Plasmodium falciparum male gametogenesisF Guinet, J A Dvorak, H Fujioka, et al.
The American Journal of Tropical Medicine and Hygiene|September 28, 1998
Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine siteY T Toure, O Doumbo, A Toure, et al.
Infection and Immunity|February 17, 2001
Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trialA W Stowers, V Cioce, R L Shimp, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular and Biochemical Parasitology|December 1, 1995
Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoesK C Williamson, D B Keister, O Muratova, et al.
Infection and Immunity|September 19, 2000
A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodiesA W Stowers, D B Keister, O Muratova, et al.
The Journal of Experimental Medicine|June 13, 1998
Adherence of erythrocytes during exflagellation of Plasmodium falciparum microgametes is dependent on erythrocyte surface sialic acid and glycophorinsT J Templeton, D B Keister, O Muratova, et al.
Molecular and Biochemical Parasitology|January 1, 1995
A genetic locus on Plasmodium falciparum chromosome 12 linked to a defect in mosquito-infectivity and male gametogenesisA B Vaidya, O Muratova, F Guinet, et al.
Parasite Immunology|September 6, 2000
Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunityP J Bustamante, D C Woodruff, J Oh, et al.
Experimental Parasitology|April 3, 2001
Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidateM M Gozar, O Muratova, D B Keister, et al.
Transfusion Medicine (Oxford, England)|June 20, 2002
In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expressionD R Chambers, J Procter, O Muratova, et al.
The Journal of Cell Biology|October 1, 1996
A developmental defect in Plasmodium falciparum male gametogenesisF Guinet, J A Dvorak, H Fujioka, et al.
The American Journal of Tropical Medicine and Hygiene|September 28, 1998
Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine siteY T Toure, O Doumbo, A Toure, et al.
Infection and Immunity|February 17, 2001
Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trialA W Stowers, V Cioce, R L Shimp, et al.
Pageof 1